We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Adhesives Research to Present Hydrophilic Adhesive Technologies

By LabMedica International staff writers
Posted on 03 Aug 2016
Adhesives Research (AR; Glen Rock, PA, USA), a leading developer and manufacturer of high-performance pressure-sensitive adhesives, tapes, specialty coatings, films, and laminates, will hold a presentation at AACC 2016 on the range of opportunities for hydrophilic adhesive technologies, which are expanding as demand for microfluidic biological tests increases. More...
They will also be presenting a range of custom tailored products, from devices that detect infectious diseases to test kits that monitor diabetes and blood coagulation.

Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.

“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”

AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.

The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.

Related Links:
Adhesives Research
American Association for Clinical Chemistry

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The AidaBREAST assay integrates multimodal data to provide patient-specific 10-year recurrence risk and individualized predictions of radiation therapy benefit (photo courtesy of PreludeDx)

Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

For women with early-stage invasive breast cancer who undergo breast-conserving surgery, clinicians must assess both the risk of locoregional recurrence and the potential benefit of adjuvant radiation therapy.... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera Inc.’s (Austin, TX, USA) multi-cancer early detection (MCED) assay has received Breakthrough Device designation (BDD) from the U.S. Food and Drug Administration (FDA). The assay analyzes cell-free... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.